VanEck Pharmaceutical ETF
Price through Oct 7, 2026 · Flows through Oct 6, 2026. Figures use the latest available records, not a live quote. Fund details retrieved Oct 7, 2026. Holdings snapshot retrieved Oct 7, 2026.
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
SOURCE: MARKET TAPE & DAILY CREATION/REDEMPTION RECORDS · 1M SHOWN · NET +$17M OVER THIS RANGE
Money keeps arriving — +$17M of net inflows over the past month, about 1.7% of the fund's asset base, while the price has returned +6.1% so far this year. At 0.36% a year it is not the cheapest way in — IWM has a reported fee of 0.19%.
COMPOSED FROM THE FUND’S OWN DAILY RECORDS · UPDATED WITH EACH REFRESH
CELL SIZE IS PORTFOLIO WEIGHT · COLOR IS THE CHANGE IN THE LATEST AVAILABLE SNAPSHOT · TOP 40 POSITIONS
| # | Holding | Weight | Price | Day | 52-wk | |
|---|---|---|---|---|---|---|
| 1 | LLYELI LILLY | 20.80% | $1188.72 | +2.7% | ||
| 2 | MRKMERCK & CO | 13.01% | $142.79 | +0.6% | ||
| 3 | NVONOVO NORDISK A S | 5.64% | $38.26 | +1.9% | ||
| 4 | PFEPFIZER | 5.05% | $28.00 | +1.8% | ||
| 5 | TEVATEVA PHARMACEUTICAL | 4.84% | $39.18 | +0.1% | ||
| 6 | BMYBRISTOL MYERS SQUIBB | 4.67% | $59.70 | +0.2% | ||
| 7 | MCKMCKESSON | 4.73% | $910.33 | -1.2% | ||
| 8 | CORCENCORA INC | 4.48% | $317.25 | +0.3% | ||
| 9 | GSKGSK | 4.41% | $47.02 | +0.9% | ||
| 10 | ABBVABBVIE | 3.75% | $271.36 | +1.8% | ||
| 11 | HLNHALEON | 3.68% | $9.02 | +1.7% | ||
| 12 | NVSNOVARTIS AG | 3.63% | $143.28 | +1.8% | ||
| 13 | AZNASTRAZENECA | 3.53% | $160.12 | +1.0% | ||
| 14 | JNJJOHNSON & JOHNSON | 3.35% | $258.45 | +1.4% | ||
| 15 | SNYSANOFI | 3.26% | $40.20 | +1.6% |
The full book, free with one sign-in.
Top 15 positions are open to everyone. Sign in once and every fund’s complete holdings — plus CSV export, watchlists, and flow alerts — unlock across the network.
Sign in to see all 27| 1 week | +1.2% |
| 1 month | -4.1% |
| 3 months | -1.9% |
| 6 months | +5.1% |
| YTD | +6.1% |
| 1 year | +17.2% |
| 3 years | — |
PRICE RETURN, DISTRIBUTIONS NOT REINVESTED
| 1 week | +$100K |
| 1 month | +$17M |
| 3 months | +$69M |
| YTD | −$302M |
| 1 year | +$303M |
CREATION/REDEMPTION DOLLARS, DAILY RECORDS
The top holding is 20.8% of the book; the top ten carry 71%. Spread across 25+ names, it behaves like roughly 12 equally-weighted positions.
VOLATILITY & DRAWDOWN FROM THE DAILY TAPE · CONCENTRATION FROM THE LATEST DISCLOSED BOOK
| Most-traded holdings, options premium | Bullish | Bearish |
|---|---|---|
| LLY ELI LILLY | $43M | $44M |
| ABBV ABBVIE | $9M | $9M |
| JNJ JOHNSON & JOHNSON | $3M | $3M |
| NVO NOVO NORDISK A S | $3M | $2M |
| PFE PFIZER | $2M | $3M |
TODAY’S OPTIONS PREMIUM IN THE FUND’S UNDERLYING NAMES
Due diligence cuts both ways. These funds sit on the same shelf and beat PPH on at least one dimension that matters — the fee, the asset base, or where the money is going.
| Fund | Fee | Assets | Flow, 1M | The case | |
|---|---|---|---|---|---|
| SPDW State Street SPDR Portfolio Developed World ex-US ETF | 0.03% | $41B | +$286M | -33bp on fee · 41× the assets · +$286M in over the month | Head-to-head |
| SPMD State Street SPDR Portfolio S&P 400 Mid Cap ETF | 0.03% | $18.4B | +$199M | -33bp on fee · 18× the assets · +$199M in over the month | Head-to-head |
| IDEV iShares Core MSCI International Developed Markets ETF | 0.04% | $32.4B | +$497M | -32bp on fee · 32× the assets · +$497M in over the month | Head-to-head |
| IGSB iShares 1-5 Year Investment Grade Corporate Bond ETF | 0.04% | $23.3B | +$575M | -32bp on fee · 23× the assets · +$575M in over the month | Head-to-head |
| IGIB iShares 5-10 Year Investment Grade Corporate Bond ETF | 0.04% | $18.6B | +$412M | -32bp on fee · 18× the assets · +$412M in over the month | Head-to-head |